MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol

MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol
复制标题

DOI:
10.1161/circresaha.116.309528
复制
发表时间:
2017-03-03
影响因子:
20.1
通讯作者:
Ono, Koh
Ono, Koh
中科院分区:
医学1区
文献类型:
--
作者:
Nishiga, Masataka;Horie, Takahiro;Ono, Koh

文献摘要

被引文献

相似文献

理论基础:心力衰竭和动脉粥样硬化有着共同的慢性炎症和纤维化的潜在机制。高度保守的microRNA(MiR)miR-33被认为是动脉粥样硬化的潜在治疗靶点,因为它调节脂质代谢和炎症。目的:探讨miR-33在心力衰竭中的作用。方法与结果:我们首先研究了扩张型心肌病患者心肌组织中miR-33a/b的表达水平。MiR-33a表达增加与血流动力学参数改善有关。为了阐明miR-33在心脏重塑中的作用,我们研究了miR-33基因缺陷(基因敲除[KO])小鼠对压力超负荷的反应。当小鼠遭受横断性主动脉收缩时,野生型左心室miR-33的表达水平显著上调。与野生型相比,野生型和miR-33KO心脏的肥大反应无差异,而心肌纤维化明显减轻。尽管心肌纤维化得到改善,miR-33KO小鼠在横动脉缩窄后表现出收缩功能受损。我们还发现心脏成纤维细胞主要负责miR-33在心脏的表达。MiR-33的缺失损害了心脏成纤维细胞的增殖,这被认为是由脂筏胆固醇含量改变引起的。此外,心脏成纤维细胞特异性miR-33基因缺陷小鼠与系统miR-33KO小鼠一样,也表现出减少由腹主动脉缩窄引起的心脏纤维化。结论:miR-33参与心脏重塑,并保留成纤维细胞中的脂筏胆固醇含量,维持重塑心脏的适应性纤维化反应。
Rationale: Heart failure and atherosclerosis share the underlying mechanisms of chronic inflammation followed by fibrosis. A highly conserved microRNA (miR), miR-33, is considered as a potential therapeutic target for atherosclerosis because it regulates lipid metabolism and inflammation. However, the role of miR-33 in heart failure remains to be elucidated.Objective: To clarify the role of miR-33 involved in heart failure.Methods and Results: We first investigated the expression levels of miR-33a/b in human cardiac tissue samples with dilated cardiomyopathy. Increased expression of miR-33a was associated with improving hemodynamic parameters. To clarify the role of miR-33 in remodeling hearts, we investigated the responses to pressure overload by transverse aortic constriction in miR-33-deficient (knockout [KO]) mice. When mice were subjected to transverse aortic constriction, miR-33 expression levels were significantly upregulated in wild-type left ventricles. There was no difference in hypertrophic responses between wild-type and miR-33KO hearts, whereas cardiac fibrosis was ameliorated in miR-33KO hearts compared with wild-type hearts. Despite the ameliorated cardiac fibrosis, miR-33KO mice showed impaired systolic function after transverse aortic constriction. We also found that cardiac fibroblasts were mainly responsible for miR-33 expression in the heart. Deficiency of miR-33 impaired cardiac fibroblast proliferation, which was considered to be caused by altered lipid raft cholesterol content. Moreover, cardiac fibroblast-specific miR-33-deficient mice also showed decreased cardiac fibrosis induced by transverse aortic constriction as systemic miR-33KO mice.Conclusion: Our results demonstrate that miR-33 is involved in cardiac remodeling, and it preserves lipid raft cholesterol content in fibroblasts and maintains adaptive fibrotic responses in the remodeling heart.